 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12 |
- ||||||| Letybo (letibotulinumtoxinA-wlbg) / Hugel, Croma Pharma
Trial completion, Trial primary completion date: Phase III Clinical Trial of "Botulax (clinicaltrials.gov) - May 4, 2015
P3, N=144, Completed, Sponsor: Hugel
Recruiting --> Completed | Trial primary completion date: Jul 2013 --> Jun 2014
- |||||||||| Letybo (letibotulinumtoxinA-wlbg) / Hugel, Croma Pharma
New P3 trial: Phase III Study of Botulax (clinicaltrials.gov) - Aug 1, 2013
P3, N=186, Recruiting, Sponsor: Hugel
- |||||||||| Letybo (letibotulinumtoxinA-wlbg) / Hugel, Croma Pharma
New P3 trial: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm (clinicaltrials.gov) - Feb 13, 2013
P3, N=172, Completed, Sponsor: Hugel
- |||||||||| Letybo (letibotulinumtoxinA-wlbg) / Hugel, Croma Pharma
New P3 trial: To Evaluate the Safety and Efficacy of Botulax (clinicaltrials.gov) - Feb 13, 2013
P3, N=262, Completed, Sponsor: Hugel
- |||||||||| Letybo (letibotulinumtoxinA-wlbg) / Hugel, Croma Pharma
New P3 trial: Phase III Clinical Trial of "Botulax (clinicaltrials.gov) - Feb 6, 2013
P3, N=144, Recruiting, Sponsor: Hugel